BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29222358)

  • 1. Leveraging precision medicine to mitigate medication-safety challenges.
    Gammal RS; Hoffman JM
    Am J Health Syst Pharm; 2017 Dec; 74(24):2031-2032. PubMed ID: 29222358
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.
    Gammal RS; Crews KR; Haidar CE; Hoffman JM; Baker DK; Barker PJ; Estepp JH; Pei D; Broeckel U; Wang W; Weiss MJ; Relling MV; Hankins J
    Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27335380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codeine Pharmacogenetics as a Proof of Concept for Pediatric Precision Medicine.
    Hudak ML
    Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27335381
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical application of pharmacogenetics in pain management.
    Smith DM; Weitzel KW; Cavallari LH; Elsey AR; Schmidt SO
    Per Med; 2018 Mar; 15(2):117-126. PubMed ID: 29714124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Utility of the Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
    Ruan X; Bumgarner GW; Labrie-Brown C; Kaye AD
    Clin J Pain; 2016 Dec; 32(12):1105-1106. PubMed ID: 26889610
    [No Abstract]   [Full Text] [Related]  

  • 6. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center.
    Schultz S; Chamberlain C; Vulcan M; Rana H; Patel B; Alexander JC
    J Opioid Manag; 2016; 12(2):119-22. PubMed ID: 27194196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer.
    Susce MT; Murray-Carmichael E; de Leon J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1356-8. PubMed ID: 16631290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescriptions for hydrocodone plummet after US tightens prescribing rules.
    McCarthy M
    BMJ; 2016 Jan; 352():i549. PubMed ID: 26819247
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach.
    Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat M; Sawant RV; Ferries E; Reeve K; Todd KH
    Res Social Adm Pharm; 2017; 13(3):503-512. PubMed ID: 27567741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
    Haynes A; Kleinschmidt K; Forrester MB; Young A
    Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone.
    Chumpitazi CE; Rees CA; Camp EA; Bernhardt MB
    J Emerg Med; 2017 Apr; 52(4):547-553. PubMed ID: 27727038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discussion.
    Surgery; 2018 Oct; 164(4):885-886. PubMed ID: 30244918
    [No Abstract]   [Full Text] [Related]  

  • 13. Pain management of musculoskeletal injuries in children: current state and future directions.
    Ali S; Drendel AL; Kircher J; Beno S
    Pediatr Emerg Care; 2010 Jul; 26(7):518-24; quiz 525-8. PubMed ID: 20622635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on the urine metabolic profile of codeine in pain patients.
    Yee DA; Atayee RS; Best BM; Ma JD
    J Anal Toxicol; 2014 Mar; 38(2):86-91. PubMed ID: 24396053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.
    Weiner SG; Baker O; Poon SJ; Rodgers AF; Garner C; Nelson LS; Schuur JD
    Ann Emerg Med; 2017 Dec; 70(6):799-808.e1. PubMed ID: 28549620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.
    Palangio M; Damask MJ; Morris E; Doyle RT; Jiang JG; Landau CJ; de Padova A
    Clin Ther; 2000 Jul; 22(7):879-92. PubMed ID: 10945514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics: why standard codeine doses can have serious toxicities or no therapeutic effect.
    Kelly PA
    Oncol Nurs Forum; 2013 Jul; 40(4):322-4. PubMed ID: 23803265
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010.
    Mazer-Amirshahi M; Mullins PM; Rasooly I; van den Anker J; Pines JM
    Acad Emerg Med; 2014 Mar; 21(3):236-43. PubMed ID: 24628748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA committee: More restrictions needed on hydrocodone combination products.
    Kuehn BM
    JAMA; 2013 Mar; 309(9):862. PubMed ID: 23462764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.